Kenneth Kabagambe’s Post

TB is a preventable and curable disease, and yet in 2022 it still took 1.3 million lives. A disease fueled by inequity, TB takes the greatest toll on vulnerable communities – with 80% of TB cases and deaths affecting the most marginalized people in low- and middle-income countries. The new Global Fund Results Report shares that in 2023... - 7.1 million people were treated for TB. - 353,000 people living with HIV and TB were on antiretroviral therapy during TB treatment. - 2 million people exposed to TB received preventive therapy. - 121,000 people were on treatment for drug-resistant TB. - 1.7 million people living with HIV on antiretroviral therapy initiated TB preventive therapy. Working together, the Global Fund partnership is fighting deadly infectious diseases, challenging the inequity that fuels them and strengthening health and community systems. #EndTB Read the full report: https://lnkd.in/ez8j8Byr

TB is the number one killer among infectious diseases and kills more people than HIV and Malaria put together, yet international funding for TB is half of that for Malaria and 13% of that of HIV. TODAY we ask for the Global Fund Allocation to TB to increase from 18% to 33%. Learn more: https://lnkd.in/gHz8rHEd" 

Tuberculosis is preventable and curable. A total of 1.3 million people died from TB in 2022 (including 167 000 people with HIV). Worldwide, TB is the second leading infectious killer after COVID-19 (above HIV and AIDS).In 2022, an estimated 10.6 million people fell ill with tuberculosis (TB) worldwide, including 5.8 million men, 3.5 million women and 1.3 million children. TB is present in all countries and age groups. TB is curable and preventable. - WHO 2024 Data on tuberculosis (TBC) in Indonesia in 2020 shows that the majority of cases (67%) occur in the productive age group (15-54 years), and 9% of cases occur in children under 15 years old. This is evidence that immediate efforts are needed to eliminate TBC. As future healthcare professionals, we are committed to contributing and striving to address the issue of TBC by providing education through posters in hospitals, especially in the Pulmonary Clinic.

Ever wondered what happens to your blood after donation? When you donate blood, it goes through a remarkable journey to save lives. Here's a glimpse into the process: 1. Collection: Your blood is collected in a sterile blood bag and blood samples are also taken for testing. 2. Processing and Testing: Your blood is separated into its components - red cells, plasma, and platelets to optimise blood usage and benefit more patients from a single blood donation. Your donated blood undergoes blood group testing, antibody screening and rigorous screening for infectious diseases such HIV, Hepatitis B virus, Hepatitis E virus, Hepatitis C virus, and syphilis to ensure its safety. 3. Labelling: After your blood is tested safe for use, it is labelled with blood group and expiry date. 4. Storage: Each component is stored under specific conditions to maintain its effectiveness until needed. 5. Distribution: Blood is dispatched to all hospitals based on their specified type and quantity requirements. 6. Transfusion: Your blood is compatible with the patient’s blood and it is now transfused to the patient. Your single donation can save up to three lives! Every drop counts, join us in this life-saving journey! Singapore Red Cross #BloodDonation #GiveBloodSaveLives

We don’t stop being The Global Fund during war, conflict, or emergencies. We adapt.   🌍 2024 Results Report: Tackling Crises with Agility & Resilience 🌍   In 2023, the world faced another wave of interconnected crises, from conflict to extreme weather events, increasing mass displacement and disrupting access to essential services. These crises, fueled by climate change, disproportionately impacted the most vulnerable communities—exacerbating inequities and threatening global health efforts.   Through innovation, increased flexibility and partnership, the Global Fund seeks to safeguard the gains made against HIV, TB and malaria in countries affected by conflict, while building strong health and community systems that can end the three diseases and prepare the world for future pandemics.   To provide a speedier response in humanitarian settings, the Global Fund builds coalitions with partners who have expertise and a comparative advantage in emergencies. These partnerships are key in strengthening our collective response, prevention, and resilience against the growing threat of climate change.   The Emergency Fund has been a vital tool in our response, providing quick and flexible financing to ensure the continuity of life-saving programs for HIV, TB, and malaria in times of crisis. In total, $131.2M was deployed to tackle various emergencies:   $48.8M for natural disasters and extreme weather $46.6M for conflict-related emergencies $21.6M for displacement crises $10M for political crises $3.3M for the Ebola pandemic $0.9M for socioeconomic reasons   🌿 Together, we're building a more resilient, equitable future—one that not only responds to crises but actively works to prevent them.

Ensuring a secure blood supply is critically dependent on voluntary blood donation. Our Erba Lisa Blood Banking reagent kits ensure blood safety by significantly reducing the risk of TTIs such as HIV, HBV, HCV, Syphilis, and Malaria. These kits provide accurate and reliable results, ensuring every unit of donated blood is safe for transfusion. Erba Transasia’s Lisa XL, is a groundbreaking Made-in-India 6-plate ELISA processor. This high-throughput analyzer, with an impressive capacity to process up to 576 tests, is equipped with advanced features, making it an ideal choice for screening transfusion-transmitted infections (TTIs) in blood banks. With these cutting-edge solutions, blood banks can confidently safeguard the health of recipients and donors alike. Learn more at https://zurl.co/Zuxx and https://zurl.co/aQ71 or contact our team at 7400058929. #IAmTransasia #WeAreErba #TTI #clinicalanalysis #laboratoryanalysis #TTIdetection #pathology #IVD #bloodbankserology #bloodsafety #safebloodtransfusion #ELISA

Ensuring a secure blood supply is critically dependent on voluntary blood donation. Our Erba Lisa Blood Banking reagent kits ensure blood safety by significantly reducing the risk of TTIs such as HIV, HBV, HCV, Syphilis, and Malaria. These kits provide accurate and reliable results, ensuring every unit of donated blood is safe for transfusion. Erba Transasia’s Lisa XL, is a groundbreaking Made-in-India 6-plate ELISA processor. This high-throughput analyzer, with an impressive capacity to process up to 576 tests, is equipped with advanced features, making it an ideal choice for screening transfusion-transmitted infections (TTIs) in blood banks. With these cutting-edge solutions, blood banks can confidently safeguard the health of recipients and donors alike. Learn more at https://zurl.co/Zuxx and https://zurl.co/aQ71 or contact our team at 7400058929. #IAmTransasia #WeAreErba #TTI #clinicalanalysis #laboratoryanalysis #TTIdetection #pathology #IVD #bloodbankserology #bloodsafety #safebloodtransfusion #ELISA

Estimates show that more than half (53·1%) of the households of patients with tuberculosis in Uganda face catastrophic expenditure, spending around 20–40% of their household income on tuberculosis care, with patients with drug-sensitive tuberculosis spending on average US$369 on tuberculosis-related care per episode. The costs are even higher for patients co-infected with HIV and tuberculosis, as these patients must simultaneously meet HIV-associated costs. However, only 3·9% of patients with tuberculosis receive some form of social protection to deal with these financial constraints.

120 containers of malaria and TB meds freely donated to Ghana left to rot More than 120 containers of free Malaria and Tuberculosis medications donated by Global Fund to Ghana have been left to rot at the Tema Port for many months. The total containers were more than this figure but the government only managed to pay to clear the medications covering HIV/AIDS leaving the needed medications for Malaria and TB to rot. These medications were freely donated to help Ghana mitigate HIV/AIDS, malaria and tuberculosis. The Global Fund has issued a final ultimatum to Ghana, warning that it will cease all funding by the end of June if the country fails to clear over 120 containers of essential drugs currently stuck at the Tema port. These containers have been held up since May 2023, despite repeated promises by the government to resolve the issue. https://lnkd.in/djyiGwiz